Patents by Inventor Stefan Fichtner-Feigl

Stefan Fichtner-Feigl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
    Patent number: 9072716
    Abstract: The present invention provides a method of treating or preventing the inflammatory response of ulcerative colitis or Crohn's disease in a subject comprising administering to the subject an effective amount of a substance that inhibits the binding of IL-13 to IL-13 receptors on NKT cells or delivers an effector molecule to the NKT cells.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: July 7, 2015
    Assignee: The United States of America, as represented by the Secretary Department of Health by Human Servies
    Inventors: Warren Strober, Ivan Fuss, Peter Mannon, Jan Preiss, Raj Puri, Koji Kawakami, Stefan Fichtner-Feigl, Atsushi Kitani
  • TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-ALPHA2
    Publication number: 20110268749
    Abstract: Disclosed herein are compositions and methods for treating or preventing cancer involving the use of a TNF-alpha antagonist, an IL-13R?2 antagonist, and/or a AP-I antagonist.
    Type: Application
    Filed: July 31, 2008
    Publication date: November 3, 2011
    Applicant: The Government of the US as Represented by the Secretary Department of Health and Human Services
    Inventors: Warren Strober, Jay A. Berzofsky, Stefan Fichtner-Feigl, Atsushi Kitani, Ivan J. Fuss, Masaki Terabe, Peter Mannon
  • Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells
    Publication number: 20090092543
    Abstract: The present invention provides a method of treating or preventing the inflammatory response of ulcerative colitis or Crohn's disease in a subject comprising administering to the subject an effective amount of a substance that inhibits the binding of IL-13 to IL-13 receptors on NKT cells or delivers an effector molecule to the NKT cells.
    Type: Application
    Filed: April 14, 2006
    Publication date: April 9, 2009
    Inventors: Warren Strober, Ivan Fuss, Peter Mannon, Jan Preiss, Raj Puri, Koji Kawakami, Stefan Fichtner-Feigl, Atsushi Kitani
  • Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides
    Publication number: 20060258604
    Abstract: Provided herein is a method of treating or preventing inflammatory bowel disease (IBD) in a subject comprising administering to the subject a therapeutically effective amount of a composition comprising an NF-?B decoy polynucleotide.
    Type: Application
    Filed: May 10, 2005
    Publication date: November 16, 2006
    Inventors: Warren Strober, Ivan Fuss, Atsushi Kitani, Stefan Fichtner-Feigl